Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $6.4 Million - $11.6 Million
100,000 Added 76.92%
230,000 $15.4 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $11 Million - $14 Million
100,000 Added 333.33%
130,000 $14.7 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $13.1 Million - $16.1 Million
-115,000 Reduced 79.31%
30,000 $4.16 Million
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $6.79 Million - $11.2 Million
90,000 Added 163.64%
145,000 $18 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $4.97 Million - $7.96 Million
-57,700 Reduced 51.2%
55,000 $5.13 Million
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $12.7 Million - $14.8 Million
112,700 New
112,700 $14.5 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $17.5 Million - $25.2 Million
205,400 Added 234.74%
292,900 $33.2 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $3.63 Million - $4.47 Million
47,500 Added 118.75%
87,500 $7.05 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $2.72 Million - $5.32 Million
40,000 New
40,000 $2.98 Million
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $1.71 Million - $2.29 Million
-16,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$80.99 - $107.93 $1.3 Million - $1.73 Million
16,000 New
16,000 $6.83 Million
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $4.3 Million - $6.81 Million
-90,000 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $3.3 Million - $5.16 Million
90,000 New
90,000 $19.7 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.